Global Immunoglobulin Products Market 2024-2028
The immunoglobulin products market is forecasted to grow by USD 9699.84 mn during 2023-2028, accelerating at a CAGR of 10.11% during the forecast period. The report on the immunoglobulin products market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by recent immunoglobulin product developments, rising prevalence of immunodeficiency disorders and autoimmune diseases, and growing geriatric population.
Technavio's immunoglobulin products market is segmented as below:
By Product
By Route Of Administration
- Intravenous (IV)
- Subcutaneous (SC)
- Intramuscular (IM)
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the advancements in biotechnology and manufacturing processes as one of the prime reasons driving the immunoglobulin products market growth during the next few years. Also, increasing adoption of subcutaneous administration and growing focus on personalized medicine will lead to sizable demand in the market.
The report on the immunoglobulin products market covers the following areas:
- Immunoglobulin products market sizing
- Immunoglobulin products market forecast
- Immunoglobulin products market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading immunoglobulin products market vendors that include ADMA Biologics Inc., Bio Products Laboratory Ltd., Biocon Ltd., CSL Ltd., GC Biopharma corp. , Grifols SA, Kedrion S.p.A, LFB SA, Novartis AG, Octapharma AG, Pfizer Inc., Serum Institute of India Pvt. Ltd., Shanghai RAAS Blood Products Co. Ltd., Taibang Biological Group Co. Ltd., Taj Pharmaceuticals Ltd., and Takeda Pharmaceutical Co. Ltd.. Also, the immunoglobulin products market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.